Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 8, 2012, Pages 2083-2088

  Macias J ^a   Viloria, M M ^a   Rivero, A ^b   De Los Santos, I ^c   Marquez M ^d   Portilla, J ^e   Di Lello, F ^a   Camacho, A ^b   Sanz Sanz, J ^c   Ojeda, G ^c   Mata, R ^a   Gomez Mateos J ^a   Pineda, J A ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ASPARTATE AMINOTRANSFERASE; ATAZANAVIR; DARUNAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; ETRAVIRINE; FOSAMPRENAVIR; GELATINASE A; LAMIVUDINE; LOPINAVIR; MARAVIROC; NEVIRAPINE; RALTEGRAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; TIPRANAVIR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROGENESIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NON INVASIVE MEASUREMENT; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; THROMBOCYTE;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CYCLOHEXANES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RNA, VIRAL; SERUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; TRIAZOLES;

EID: 84866364024     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1546-5     Document Type: Article

References (21)

1. Merchante N, Girón-González JA, González-Serrano M et al (2006) Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 20:49-57 (Pubitemid 41818114)
2. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL (2002) Hepatitis C and progression of HIV disease. JAMA 288:199- 206 (Pubitemid 34755280)
3. Pineda JA, García-García JA, Aguilar-Guisado M et al (2007) Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 46:622-630 (Pubitemid 47436106)
4. Thein HH, Yi Q, Dore GJ, Krahn MD (2008) Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 15:1979-1991
5. Macías J, von Wichmann MA, Rivero A et al (2010) Fast liver damage progression in HIV/HCV co-infected patients in spite of effective HAART. 17th Conference on Retroviruses and Opportunistic Infections. Abstract 659
6. Berenguer J, Alvarez-Pellicer J, Martín PM et al (2009) Sustained virological response to interferon plus ribavirin reduces liverrelated complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 50:407-413
7. Mehta SH, Genberg BL, Astemborski J et al (2008) Limited uptake of hepatitis C treatment among injection drug users. J Community Health 33:126-133
8. Pineda JA, Mira JA, Gil Ide L, et al (2007) Influence of concomitant antiretroviral therapy on the rate of sustained virologic response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients. J Antimicrob Chemother 60:1347-1354 (Pubitemid 350168332)
9. Munshi N, Balasbramanian A, Koziel M, Ganju R, Groopman J (2003) Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis 188:1192-1204 (Pubitemid 37338984)
10. Vlahakis S, Villasis-Keever A, Gomez T, Bren GD, Paya CV (2003) Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. J Infect Dis 188:1455-1460 (Pubitemid 37523930)
11. Huynh ML, Fadok VA, Henson PM (2002) Phosphatidylserinedependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109:41-50 (Pubitemid 34052540)
12. Lin W, Weinberg E, Tai A et al (2008) HIV increases HCV replication in a TGF-b1-dependent manner. Gastroenterology 134:803-811 (Pubitemid 351312737)
13. Brenner DA (2009) Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc 120:361-368
14. Bruno R, Galastri S, Sacchi P et al (2010) The HIV envelope protein GP120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut 59:513-520
15. Tuyama AC, Hong F, Saiman Y et al (2010) Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 52:612-622
16. Castera L, Forns X, Alberti A (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48:835-847
17. Neuman MG, Benhamou JP, Malkiewicz IM et al (2002) Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis. J Viral Hepatol 9:134-140 (Pubitemid 36002477)
18. Yoshiji H, Noguchi R, Kojima H et al (2006) Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C. World J Gastroenterol 12:6786-6791 (Pubitemid 44811399)
19. Macías J, Japón MA, Sáez C et al (2005) Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection. J Infect Dis 192:1566-1576
20. Bräu N, Salvatore M, Ríos-Bedoya CF et al (2006) Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 44:47-55 (Pubitemid 41772515)
21. Macías J, Berenguer J, Japón MA et al (2009) Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology 50:1056-1063